NXS 2.99% 32.5¢ next science limited

Bacterial biofilms are most problematic where topical treatments...

  1. 6,767 Posts.
    lightbulb Created with Sketch. 1714
    Bacterial biofilms are most problematic where topical treatments (detoll, iodine etc) would be ineffective if applied; BlastX’s primary market is for use during surgery.

    It sounds like a product with a lot of promise. Changing surgical behaviours to adopt this product is where the hard work currently is; over time the efficacy of the product should speak for itself.
 
watchlist Created with Sketch. Add NXS (ASX) to my watchlist
(20min delay)
Last
32.5¢
Change
-0.010(2.99%)
Mkt cap ! $94.80M
Open High Low Value Volume
34.5¢ 34.5¢ 31.5¢ $32.36K 96.42K

Buyers (Bids)

No. Vol. Price($)
2 6217 32.0¢
 

Sellers (Offers)

Price($) Vol. No.
32.5¢ 29495 1
View Market Depth
Last trade - 16.10pm 29/03/2024 (20 minute delay) ?
Last
32.5¢
  Change
-0.010 ( 3.68 %)
Open High Low Volume
35.3¢ 35.3¢ 32.0¢ 61830
Last updated 15.59pm 29/03/2024 ?
NXS (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.